Alpha blocker: Clinical Trials

3 trials of Alpha blocker, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 terminated. 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1
Phase 41Completed 1

Follow Alpha blocker: new trials by email Literature Review of Alpha blocker trials Research Report on Alpha blocker

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Management and Outcome of Scorpion Sting in Children
Alpha blocker - Scorpion Stings
Not yet recruitingAssiut University702024-11-012024-09-26
Prazosin to Prevent COVID-19 (PREVENT-COVID Trial)
Prazosin, Standard of care - COVID-19
Phase 2TerminatedJohns Hopkins University52020-05-132023-04-10
A Study Comparing the Efficacy of an Alpha Blocker Versus an Alpha Blocker Plus Solifenacin in Men With Overactive Bladder
Alpha blocker, placebo, solifenacin - Urinary Bladder, Overactive
Phase 4CompletedKYU-SUNG LEE942008-06-012016-01-07

Conditions studied

COVID-19 (1)  ·  Cytokine Release Syndrome (1)  ·  Respiratory Distress Syndrome (1)  ·  Scorpion Stings (1)  ·  Urinary Bladder, Overactive (1)

Sponsors

Assiut University (1)  ·  Johns Hopkins University (1)  ·  KYU-SUNG LEE (1)

Countries

Egypt (1)  ·  South Korea (1)  ·  United States (1)

Top investigators

Chetan Bettegowda, MD/PhD (1)

Results publications

PMID 14660839, PMID 24384790